Dianthus Therapeutics, Inc. /DE/ (DNTH) Deferred Tax Assets, Valuation Allowance USD 2015 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2015 to 2023.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $123 M, a 967% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $123 M +$112 M +967% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $11.6 M +$6.37 M +123% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $5.19 M +$3.89 M +297% Dec 31, 2021 10-K 2024-03-21
Q4 2020 $1.31 M -$50.9 M -97.5% Dec 31, 2020 8-K 2023-12-21
Q4 2019 $52.2 M +$23 M +78.7% Dec 31, 2019 10-K 2022-03-08
Q4 2018 $29.2 M +$16.8 M +135% Dec 31, 2018 10-K 2021-03-03
Q4 2017 $12.5 M +$8.93 M +252% Dec 31, 2017 10-K 2020-03-03
Q4 2016 $3.54 M +$3.41 M +2644% Dec 31, 2016 10-K 2020-03-03
Q4 2015 $129 K Dec 31, 2015 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.